Effect of Chinese Herbal Medicine on Kidney Function in Non-Diabetic CKD

This study is a randomized controlled pilot trial designed to evaluate the effects and safety of a traditional Chinese medicine formula (CKD-1) as an add-on therapy to standard treatment in patients with stage 3-4 non-diabetic chronic kidney disease. Eligible participants will be randomly assigned to receive either standard care alone or standard care combined with CKD-1 for 12 weeks. Kidney function, urine protein levels, and quality of life will be assessed before and after the intervention. The study aims to provide preliminary evidence on whether CKD-1 can improve renal function and quality of life in this patient population.

NCT Number	NCT07657338
Lead Sponsor	China Medical University Hospital Collaborators: China Medical University Beigang Hospital
Conditions	Non-diabetic Chronic Kidney Disease
Enrollment	66 participants
Start Date	2026-06-11
Primary Completion	2026-12-31 (estimated)
Study Completion	2026-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-18